Skin Cancer Drug Wins FDA Approval

WASHINGTON D.C. -- A new weapon against skin cancer has federal approval.
The FDA has green-lighted a pill that treats an advanced form of the most common form of skin cancer.
Erivedge is the first drug to get FDA approval to treat the advanced form of basal cell carcinoma.
The Roche medication has been approved for adults with cancer that has spread or can't be treated with surgery or radiation.
Regulatory documents show that the once-a-day medication is expected to cost $7,500 a month.
The course of treatment is estimated at 10-months.

Copyright 2012 by VERTEXNews/Newsroom Solutions

More Stories

Don't Miss

Latest News